COVID-19 pandemic in Kiribati


== COVID-19 pandemic in Kiribati ==
The COVID-19 pandemic in Kiribati is part of the worldwide COVID-19 pandemic caused by the SARS-CoV-2 virus. Kiribati, an island nation in the central Pacific Ocean, reported its first confirmed case of COVID-19 on November 18, 2021.
Background[edit]
The COVID-19 pandemic began in Wuhan, China, in December 2019. The virus spread rapidly across the globe, leading the World Health Organization (WHO) to declare it a Public Health Emergency of International Concern on January 30, 2020, and a pandemic on March 11, 2020.
Timeline[edit]
2021[edit]
- November 18: Kiribati reported its first confirmed case of COVID-19. The case was detected in a traveler who arrived on a repatriation flight from Fiji.
Government Response[edit]
The government of Kiribati implemented several measures to prevent the spread of COVID-19, including:
- **Travel Restrictions**: Entry into Kiribati was restricted, with mandatory quarantine for incoming travelers.
- **Public Health Measures**: Social distancing, mask mandates, and public awareness campaigns were initiated to educate the population about the virus and preventive measures.
Impact[edit]
The COVID-19 pandemic had significant impacts on Kiribati, including:
- **Healthcare System**: The limited healthcare infrastructure faced challenges in managing potential outbreaks.
- **Economy**: The pandemic affected the economy, particularly the tourism sector, which is a vital part of Kiribati's economy.
- **Education**: Schools were temporarily closed, and remote learning was implemented where possible.
Vaccination[edit]
Kiribati began its COVID-19 vaccination campaign in 2021, with vaccines provided through the COVAX initiative. The government prioritized frontline workers, the elderly, and individuals with underlying health conditions.
See Also[edit]
- COVID-19 pandemic by country and territory
- COVID-19 pandemic in Oceania
- Public health emergency
- Pandemic
Related Pages[edit]
| COVID-19 pandemic in Oceania | ||||||
|---|---|---|---|---|---|---|
|
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
